Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nimmrich

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Genes, Chromosomes & Cancer|May 20, 1998
A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patientsO Müller, I Nimmrich, U Finke, et al.
Current Issues in Molecular Biology|November 16, 2002
Epigenomics: genome-wide study of methylation phenomenaK L Novik, I Nimmrich, B Genc, et al.
Human Genetics|September 1, 1997
Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAPI Nimmrich, W Friedl, R Kruse, et al.
International Journal of Oncology|June 9, 2005
Methylation discriminators in NSCLC identified by a microarray based approachJ K Field, T Liloglou, S Warrak, et al.
Cancer Letters|December 1, 2000
Seven genes that are differentially transcribed in colorectal tumor cell linesI Nimmrich, S Erdmann, U Melchers, et al.
Cancer Letters|March 15, 2001
The novel ependymin related gene UCC1 is highly expressed in colorectal tumor cellsI Nimmrich, S Erdmann, U Melchers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2017
Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trialP Christopoulos, W Engel-Riedel, C Grohé, et al.
Breast (Edinburgh, Scotland)|August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trialJ Huober, P A Fasching, M Barsoum, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Genes, Chromosomes & Cancer|May 20, 1998
A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patientsO Müller, I Nimmrich, U Finke, et al.
Current Issues in Molecular Biology|November 16, 2002
Epigenomics: genome-wide study of methylation phenomenaK L Novik, I Nimmrich, B Genc, et al.
Human Genetics|September 1, 1997
Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAPI Nimmrich, W Friedl, R Kruse, et al.
International Journal of Oncology|June 9, 2005
Methylation discriminators in NSCLC identified by a microarray based approachJ K Field, T Liloglou, S Warrak, et al.
Cancer Letters|December 1, 2000
Seven genes that are differentially transcribed in colorectal tumor cell linesI Nimmrich, S Erdmann, U Melchers, et al.
Cancer Letters|March 15, 2001
The novel ependymin related gene UCC1 is highly expressed in colorectal tumor cellsI Nimmrich, S Erdmann, U Melchers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 24, 2017
Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trialP Christopoulos, W Engel-Riedel, C Grohé, et al.
Breast (Edinburgh, Scotland)|August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trialJ Huober, P A Fasching, M Barsoum, et al.
Pageof 1